---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-049988"
form_type: "8-K"
ticker: "VCNX"
cik: "0001205922"
company_name: "VACCINEX, INC."
filed_at: "2025-03-07T23:59:59+00:00"
generated_at: "2026-05-25T03:13:39.726013+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Vaccinex voluntarily delists from Nasdaq; Form 25 filing expected March 17, 2025

## Summary
- Nasdaq trading suspended since December 18, 2024 following a hearing panel determination to delist.
- Company notified Nasdaq on March 7, 2025 of its intention to delist; filing Form 25 on or about March 17.
- Stock will continue to trade on OTC Pink under symbol VCNX.
- Vaccinex plans to continue development of pepinemab in Alzheimer's and cancer via partnerships and grants.

## SEC filing metadata
- accession: 0001193125-25-049988
- form_type: 8-K
- ticker: VCNX
- cik: 0001205922
- company_name: VACCINEX, INC.
- filed_at: 2025-03-07T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1205922/000119312525049988/0001193125-25-049988-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1205922/000119312525049988/d811414d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-049988
- JSON: https://secwatch.observer/filing/0001193125-25-049988.json
- Plain text: https://secwatch.observer/filing/0001193125-25-049988.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.